Thyroid Gland Medullary Carcinoma — Trials

Thyroid Gland Medullary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

105 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 32%
Top sponsor: Eli Lilly and Company
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01915485	Radiolabeled Molecules for Medullary Thyroid Cancer	unknown	Phase 4	20	Instituto Nacional de Cancer, BrazilOTHER_GOV	1	Sep 7, 2016	clinicaltrials

Data updated 23 days agoSource updated Sep 7, 2016source: clinicaltrials